English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Current susceptibility testing recommendations for β-hemolytic streptococci outline testing for clindamycin resistance, including inducible resistance by a positive D-zone phenotype. However, few studies describe the prevalence of clindamycin resistance among invasive GCS and GGS organisms. This study aims to describe the prevalence of clindamycin resistance among GCS/GGS compared with invasive group A streptococci (GAS) during the same period in a large United States health system. Methods Streptococcus isolates from blood, tissue, and body fluids (n = 298) recorded from January 1, 2013 to May 1, 2017 were audited using SafetySurveillor® software. Members of the anginosus-group streptococci were excluded. Specimens submitted to the clinical microbiology laboratory were grown in 5% CO2 on colistin-nalidixic-acid agar, Mueller–Hinton 5% sheep blood agar, and chocolate agar. Cultures positive for β-hemolytic streptococci were identified to the species level via MALDI-TOF MS. Disk diffusion D-zone testing was performed with 0.5 McFarland standards using erythromycin (15 μg) and clindamycin (2 μg) disks 12 mm apart on Mueller–Hinton 5% sheep blood agar plates incubated at 35°C in 5% CO2 for 20–24 hours. Susceptibilities to penicillin, erythromycin, clindamycin, and vancomycin were recorded per current CLSI breakpoints. Results A total of n = 212 GCS/GGS isolates were tested, of which n = 61 (28.8%) demonstrated clindamycin resistance; 85.2% were clindamycin resistant via a positive D-zone phenotype compared with 14.8% that were constitutively clindamycin resistant. A total of n = 86 GAS isolates were tested, of which n = 9 (10%) demonstrated clindamycin resistance; 44% reported clindamycin resistance via a positive D-zone phenotype compared with 56% which were constitutively clindamycin resistant. Conclusion Clindamycin resistance among GCS and GGS was present in 24.5% of the isolates tested compared with 10% for GAS. As a proportion of the total number of isolates tested, inducible resistance was 14.5% more frequent among GCS and GGS than was observed for GAS. This study demonstrates a higher proportional level of clindamycin resistance in GCS/GGC compared with GAS infections detected over the same study period. Disclosures All authors: No reported disclosures.

open forum infectious diseases

Inducible Clindamycin Resistance Is More Common in Lancefield groups C and G Streptococci Compared with group A in Clinical Specimens: A Single-center Experience, 2013 to 2016